

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37364409 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.37364409 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.93229367 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.93229367 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.51355294 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.78199251 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.78199251 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.78199251 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73765346 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.71622410 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.68781314 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.40763329 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.39890003 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.39114751 |
| 15 | urea metabolic process (GO:0019627) | 5.36715333 |
| 16 | urea cycle (GO:0000050) | 5.36715333 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.33112534 |
| 18 | regulation of protein activation cascade (GO:2000257) | 5.14790526 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.13723385 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.10993653 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.10116374 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.05134439 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 4.94556825 |
| 24 | cysteine metabolic process (GO:0006534) | 4.94051584 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.86718577 |
| 26 | protein carboxylation (GO:0018214) | 4.86718577 |
| 27 | regulation of complement activation (GO:0030449) | 4.79091303 |
| 28 | bile acid metabolic process (GO:0008206) | 4.77330165 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.76392812 |
| 30 | tyrosine metabolic process (GO:0006570) | 4.76011548 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.60671341 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.54634707 |
| 33 | coenzyme catabolic process (GO:0009109) | 4.50303862 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.42180476 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.41168249 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 4.39842409 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.38739623 |
| 38 | alpha-amino acid catabolic process (GO:1901606) | 4.37659395 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36660708 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 4.35246044 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.33510073 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.33510073 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.33510073 |
| 44 | lysine metabolic process (GO:0006553) | 4.28154525 |
| 45 | lysine catabolic process (GO:0006554) | 4.28154525 |
| 46 | glutamate metabolic process (GO:0006536) | 4.20573763 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.17324272 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.17324272 |
| 49 | cellular modified amino acid catabolic process (GO:0042219) | 4.14692825 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.12725993 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.12725993 |
| 52 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.12612706 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.10136703 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.06527570 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 4.04780254 |
| 56 | phospholipid efflux (GO:0033700) | 4.04134332 |
| 57 | ethanol oxidation (GO:0006069) | 4.01555503 |
| 58 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.00385772 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00233792 |
| 60 | cell migration in hindbrain (GO:0021535) | 3.99078981 |
| 61 | arginine metabolic process (GO:0006525) | 3.95158849 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.94531620 |
| 63 | amine catabolic process (GO:0009310) | 3.94531620 |
| 64 | cholesterol efflux (GO:0033344) | 3.90524293 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.88532983 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.83205187 |
| 67 | cellular glucuronidation (GO:0052695) | 3.82311161 |
| 68 | ketone body metabolic process (GO:1902224) | 3.79011749 |
| 69 | regulation of axon guidance (GO:1902667) | 3.76889112 |
| 70 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.76493823 |
| 71 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.72537171 |
| 72 | glycine metabolic process (GO:0006544) | 3.72503032 |
| 73 | fibrinolysis (GO:0042730) | 3.71920624 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 3.71819128 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.69323969 |
| 76 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.68539807 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.66524527 |
| 78 | negative regulation of protein activation cascade (GO:2000258) | 3.65829755 |
| 79 | ear development (GO:0043583) | 3.65108734 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.62832424 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.61905486 |
| 82 | complement activation, classical pathway (GO:0006958) | 3.60827144 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60251762 |
| 84 | cofactor catabolic process (GO:0051187) | 3.59206480 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.59176918 |
| 86 | cytolysis (GO:0019835) | 3.57892420 |
| 87 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.56839305 |
| 88 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.56247894 |
| 89 | complement activation (GO:0006956) | 3.53455719 |
| 90 | drug catabolic process (GO:0042737) | 3.50471343 |
| 91 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.49768641 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.49716999 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.47264584 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.45945896 |
| 95 | neuron recognition (GO:0008038) | 3.44696499 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.44416332 |
| 97 | organic acid catabolic process (GO:0016054) | 3.44416332 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42466751 |
| 99 | protein activation cascade (GO:0072376) | 3.41678258 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.39600216 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.38720528 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.37406645 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.37406645 |
| 104 | negative regulation of fatty acid transport (GO:2000192) | 3.37324618 |
| 105 | heme transport (GO:0015886) | 3.37234672 |
| 106 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.35414663 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.33833866 |
| 108 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.33772932 |
| 109 | very long-chain fatty acid metabolic process (GO:0000038) | 3.33339408 |
| 110 | axonal fasciculation (GO:0007413) | 3.33061536 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.32349297 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.31504916 |
| 113 | alkaloid metabolic process (GO:0009820) | 3.31053461 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30833191 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30833191 |
| 116 | apical protein localization (GO:0045176) | 3.30136215 |
| 117 | axon extension involved in axon guidance (GO:0048846) | 3.26806496 |
| 118 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.26806496 |
| 119 | negative regulation of axon guidance (GO:1902668) | 3.22658736 |
| 120 | metanephric mesenchyme development (GO:0072075) | 3.21380039 |
| 121 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.15890058 |
| 122 | collagen fibril organization (GO:0030199) | 3.15829746 |
| 123 | embryonic eye morphogenesis (GO:0048048) | 3.10044814 |
| 124 | axon extension (GO:0048675) | 3.09378653 |
| 125 | vagina development (GO:0060068) | 3.06942256 |
| 126 | kidney mesenchyme development (GO:0072074) | 3.06081911 |
| 127 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.02086419 |
| 128 | paraxial mesoderm development (GO:0048339) | 3.01196610 |
| 129 | eye morphogenesis (GO:0048592) | 3.00611304 |
| 130 | uterus development (GO:0060065) | 2.98968975 |
| 131 | myoblast fusion (GO:0007520) | 2.95907535 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.94199352 |
| 133 | establishment of planar polarity (GO:0001736) | 2.90131481 |
| 134 | establishment of tissue polarity (GO:0007164) | 2.90131481 |
| 135 | chondrocyte development (GO:0002063) | 2.89588872 |
| 136 | camera-type eye morphogenesis (GO:0048593) | 2.86154534 |
| 137 | negative regulation of embryonic development (GO:0045992) | 2.84639128 |
| 138 | asymmetric protein localization (GO:0008105) | 2.78613423 |
| 139 | semaphorin-plexin signaling pathway (GO:0071526) | 2.78081272 |
| 140 | cell proliferation involved in metanephros development (GO:0072203) | 2.75575059 |
| 141 | protein heterotrimerization (GO:0070208) | 2.73885488 |
| 142 | mesenchyme morphogenesis (GO:0072132) | 2.73203079 |
| 143 | dendrite morphogenesis (GO:0048813) | 2.72798298 |
| 144 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.72417681 |
| 145 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.72370386 |
| 146 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.71690480 |
| 147 | glomerular basement membrane development (GO:0032836) | 2.70369928 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66799901 |
| 149 | cardiac right ventricle morphogenesis (GO:0003215) | 2.66365427 |
| 150 | innervation (GO:0060384) | 2.60637499 |
| 151 | mesonephros development (GO:0001823) | 2.59963874 |
| 152 | dopaminergic neuron differentiation (GO:0071542) | 2.59795536 |
| 153 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.59126807 |
| 154 | ganglion development (GO:0061548) | 2.58661980 |
| 155 | neuron projection extension (GO:1990138) | 2.56114990 |
| 156 | regulation of establishment of planar polarity (GO:0090175) | 2.55389219 |
| 157 | maternal placenta development (GO:0001893) | 2.49707950 |
| 158 | mating behavior (GO:0007617) | 2.42860998 |
| 159 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.42742276 |
| 160 | ectodermal placode formation (GO:0060788) | 2.42532752 |
| 161 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.42060318 |
| 162 | response to water (GO:0009415) | 2.42048195 |
| 163 | body morphogenesis (GO:0010171) | 2.41291797 |
| 164 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.40783162 |
| 165 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.40780955 |
| 166 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.40205866 |
| 167 | female genitalia development (GO:0030540) | 2.40053921 |
| 168 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.39271328 |
| 169 | negative chemotaxis (GO:0050919) | 2.38765183 |
| 170 | endocardial cushion morphogenesis (GO:0003203) | 2.36925406 |
| 171 | sympathetic nervous system development (GO:0048485) | 2.36659321 |
| 172 | adherens junction assembly (GO:0034333) | 2.36396310 |
| 173 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.35291509 |
| 174 | mesenchymal to epithelial transition (GO:0060231) | 2.34695317 |
| 175 | endothelial cell chemotaxis (GO:0035767) | 2.34110940 |
| 176 | developmental growth involved in morphogenesis (GO:0060560) | 2.33982324 |
| 177 | protein retention in ER lumen (GO:0006621) | 2.31343365 |
| 178 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.31094138 |
| 179 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.29906988 |
| 180 | facial nerve structural organization (GO:0021612) | 2.28712846 |
| 181 | dopamine receptor signaling pathway (GO:0007212) | 2.26503442 |
| 182 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.25531490 |
| 183 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.25077560 |
| 184 | bone trabecula formation (GO:0060346) | 2.24907696 |
| 185 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.24804232 |
| 186 | norepinephrine metabolic process (GO:0042415) | 2.23795316 |
| 187 | cochlea morphogenesis (GO:0090103) | 2.23043677 |
| 188 | skeletal muscle organ development (GO:0060538) | 2.22892663 |
| 189 | convergent extension (GO:0060026) | 2.22317524 |
| 190 | positive regulation of axon extension (GO:0045773) | 2.19706072 |
| 191 | negative regulation of organelle assembly (GO:1902116) | 2.18200225 |
| 192 | negative regulation of catenin import into nucleus (GO:0035414) | 2.18083012 |
| 193 | striated muscle atrophy (GO:0014891) | 2.17648106 |
| 194 | nucleobase catabolic process (GO:0046113) | 2.17029367 |
| 195 | skin morphogenesis (GO:0043589) | 2.16358770 |
| 196 | positive regulation of mesonephros development (GO:0061213) | 2.16227937 |
| 197 | negative regulation of cell size (GO:0045792) | 2.15694457 |
| 198 | cellular response to prostaglandin stimulus (GO:0071379) | 2.15466473 |
| 199 | developmental cell growth (GO:0048588) | 2.15165316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.78328289 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.70362706 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.52474106 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.34446252 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24184229 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.48189520 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.06719404 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.62056007 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.53512928 |
| 10 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.45789163 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.33431303 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.16957446 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.79095627 |
| 14 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.38210519 |
| 15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.20366585 |
| 16 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.95634166 |
| 17 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.89277018 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.79264572 |
| 19 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.74206136 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72964571 |
| 21 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72368918 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67365884 |
| 23 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.63118051 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57807632 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57009614 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55055468 |
| 27 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54719003 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54405859 |
| 29 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.47403703 |
| 30 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.46545887 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43141260 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39346534 |
| 33 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.35789676 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34378013 |
| 35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.34190805 |
| 36 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.33790809 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31946469 |
| 38 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30427756 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29364736 |
| 40 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.28679240 |
| 41 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28230723 |
| 42 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27619763 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27354582 |
| 44 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.26940492 |
| 45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26717649 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24892546 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24441169 |
| 48 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22408106 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21985712 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.21419835 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20730002 |
| 52 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19309365 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18159013 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16558359 |
| 55 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16491366 |
| 56 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15792738 |
| 57 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15471251 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14991124 |
| 59 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13914885 |
| 60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13170397 |
| 61 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.12709819 |
| 62 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.12709819 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12652310 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12431415 |
| 65 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10961999 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10183701 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10151094 |
| 68 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09207996 |
| 69 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.08849566 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08039576 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06553398 |
| 72 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05990120 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05355650 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04504473 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04127736 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03649292 |
| 77 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02896985 |
| 78 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02771168 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00921776 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00710763 |
| 81 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00704304 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98890841 |
| 83 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97773359 |
| 84 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.97596729 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97541399 |
| 86 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.97071224 |
| 87 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.96212597 |
| 88 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96131545 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95733448 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94979978 |
| 91 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93320181 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91788206 |
| 93 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91270870 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90806115 |
| 95 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.89604184 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89509879 |
| 97 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89355352 |
| 98 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88192466 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87927339 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87927339 |
| 101 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87767948 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87351839 |
| 103 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87301714 |
| 104 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86613843 |
| 105 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.85193837 |
| 106 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84631651 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.83410453 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82892370 |
| 109 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82555095 |
| 110 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81714965 |
| 111 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.81530939 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80989216 |
| 113 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80494164 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79667885 |
| 115 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79543303 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79292487 |
| 117 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78770166 |
| 118 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.78373600 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75424613 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74993756 |
| 121 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73230141 |
| 122 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.73133187 |
| 123 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.71800761 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71665926 |
| 125 | P300_19829295_ChIP-Seq_ESCs_Human | 0.69206175 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69090032 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.68968798 |
| 128 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.68544479 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68442765 |
| 130 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.67087408 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64078271 |
| 132 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.62927524 |
| 133 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.62495207 |
| 134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.62251445 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.61755134 |
| 136 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.60474919 |
| 137 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.60027101 |
| 138 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.59374330 |
| 139 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.58415688 |
| 140 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.57865577 |
| 141 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.56164871 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55544696 |
| 143 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55235402 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54151881 |
| 145 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.54036100 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.53358290 |
| 147 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.52867105 |
| 148 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.52783578 |
| 149 | * AR_19668381_ChIP-Seq_PC3_Human | 0.52704178 |
| 150 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.52516880 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52361268 |
| 152 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.52347755 |
| 153 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.52256660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.44403397 |
| 2 | MP0005360_urolithiasis | 7.07663452 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.05163717 |
| 4 | MP0005365_abnormal_bile_salt | 5.76839750 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.82605061 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 4.22232320 |
| 7 | MP0003252_abnormal_bile_duct | 3.65935951 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.49578826 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.33750663 |
| 10 | MP0005503_abnormal_tendon_morphology | 3.28568096 |
| 11 | MP0009840_abnormal_foam_cell | 2.94478380 |
| 12 | MP0005275_abnormal_skin_tensile | 2.79629357 |
| 13 | MP0005083_abnormal_biliary_tract | 2.77948108 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.68341590 |
| 15 | MP0005332_abnormal_amino_acid | 2.59185550 |
| 16 | MP0003195_calcinosis | 2.41508020 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.31474867 |
| 18 | MP0003868_abnormal_feces_composition | 2.03643507 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.00489554 |
| 20 | * MP0003942_abnormal_urinary_system | 1.98379811 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.96463860 |
| 22 | * MP0002184_abnormal_innervation | 1.91599422 |
| 23 | MP0002108_abnormal_muscle_morphology | 1.85306321 |
| 24 | MP0000609_abnormal_liver_physiology | 1.84376749 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.84193239 |
| 26 | * MP0000534_abnormal_ureter_morphology | 1.80879572 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.78913199 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.76051597 |
| 29 | MP0004272_abnormal_basement_membrane | 1.75039182 |
| 30 | MP0001299_abnormal_eye_distance/ | 1.74139598 |
| 31 | MP0001958_emphysema | 1.72879249 |
| 32 | MP0005409_darkened_coat_color | 1.68807393 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.59988695 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.50246937 |
| 35 | MP0003329_amyloid_beta_deposits | 1.49571444 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48809364 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.46733066 |
| 38 | MP0003011_delayed_dark_adaptation | 1.46553141 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.42674284 |
| 40 | MP0003122_maternal_imprinting | 1.40091598 |
| 41 | MP0000604_amyloidosis | 1.38131749 |
| 42 | MP0000733_abnormal_muscle_development | 1.36302886 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.34540392 |
| 44 | MP0009697_abnormal_copulation | 1.32392798 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.31953358 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.31340959 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.29332214 |
| 48 | MP0001542_abnormal_bone_strength | 1.28973499 |
| 49 | MP0005508_abnormal_skeleton_morphology | 1.25975047 |
| 50 | MP0003941_abnormal_skin_development | 1.25879235 |
| 51 | MP0002932_abnormal_joint_morphology | 1.25817335 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.23820508 |
| 53 | MP0009250_abnormal_appendicular_skeleto | 1.23818586 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 1.23647625 |
| 55 | MP0005171_absent_coat_pigmentation | 1.21593919 |
| 56 | MP0002697_abnormal_eye_size | 1.21503840 |
| 57 | MP0003385_abnormal_body_wall | 1.20057291 |
| 58 | MP0004233_abnormal_muscle_weight | 1.19363773 |
| 59 | * MP0000955_abnormal_spinal_cord | 1.19073705 |
| 60 | MP0003690_abnormal_glial_cell | 1.17518903 |
| 61 | MP0001764_abnormal_homeostasis | 1.16547126 |
| 62 | MP0003283_abnormal_digestive_organ | 1.14913571 |
| 63 | * MP0002751_abnormal_autonomic_nervous | 1.14354104 |
| 64 | MP0003115_abnormal_respiratory_system | 1.13649326 |
| 65 | MP0000751_myopathy | 1.13173444 |
| 66 | MP0003880_abnormal_central_pattern | 1.11796277 |
| 67 | MP0005451_abnormal_body_composition | 1.10805686 |
| 68 | MP0002116_abnormal_craniofacial_bone | 1.09528502 |
| 69 | MP0003279_aneurysm | 1.06914253 |
| 70 | MP0005647_abnormal_sex_gland | 1.06319495 |
| 71 | MP0001849_ear_inflammation | 1.04186426 |
| 72 | MP0000383_abnormal_hair_follicle | 1.03736988 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.01280342 |
| 74 | MP0003935_abnormal_craniofacial_develop | 0.99680176 |
| 75 | MP0002822_catalepsy | 0.99356952 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.98142214 |
| 77 | MP0000428_abnormal_craniofacial_morphol | 0.98076006 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.97059093 |
| 79 | MP0005197_abnormal_uvea_morphology | 0.96111215 |
| 80 | MP0002092_abnormal_eye_morphology | 0.95385627 |
| 81 | MP0002796_impaired_skin_barrier | 0.95189808 |
| 82 | MP0000049_abnormal_middle_ear | 0.95021997 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 0.94151156 |
| 84 | * MP0000462_abnormal_digestive_system | 0.92601443 |
| 85 | * MP0003861_abnormal_nervous_system | 0.92375776 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.88971863 |
| 87 | MP0002060_abnormal_skin_morphology | 0.88556192 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.88519170 |
| 89 | MP0003091_abnormal_cell_migration | 0.88382624 |
| 90 | MP0003755_abnormal_palate_morphology | 0.87981006 |
| 91 | MP0000467_abnormal_esophagus_morphology | 0.86930082 |
| 92 | MP0002160_abnormal_reproductive_system | 0.86573813 |
| 93 | * MP0002081_perinatal_lethality | 0.86524147 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.86425543 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.86167477 |
| 96 | MP0004859_abnormal_synaptic_plasticity | 0.85807439 |
| 97 | MP0004270_analgesia | 0.85800007 |
| 98 | MP0003123_paternal_imprinting | 0.85737265 |
| 99 | MP0005535_abnormal_body_temperature | 0.85411551 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.85329861 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.85224074 |
| 102 | MP0009672_abnormal_birth_weight | 0.84878558 |
| 103 | MP0003634_abnormal_glial_cell | 0.84451116 |
| 104 | MP0000598_abnormal_liver_morphology | 0.84429084 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.81546470 |
| 106 | MP0002152_abnormal_brain_morphology | 0.80871807 |
| 107 | MP0002282_abnormal_trachea_morphology | 0.80757997 |
| 108 | MP0002114_abnormal_axial_skeleton | 0.79624879 |
| 109 | * MP0002882_abnormal_neuron_morphology | 0.78719190 |
| 110 | MP0009703_decreased_birth_body | 0.77983723 |
| 111 | MP0005248_abnormal_Harderian_gland | 0.77956170 |
| 112 | MP0002233_abnormal_nose_morphology | 0.77917559 |
| 113 | MP0002177_abnormal_outer_ear | 0.77657681 |
| 114 | MP0004858_abnormal_nervous_system | 0.77064085 |
| 115 | MP0003938_abnormal_ear_development | 0.76884383 |
| 116 | MP0009764_decreased_sensitivity_to | 0.74551431 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.73116907 |
| 118 | MP0000163_abnormal_cartilage_morphology | 0.73051939 |
| 119 | MP0005408_hypopigmentation | 0.71474540 |
| 120 | MP0001340_abnormal_eyelid_morphology | 0.71287322 |
| 121 | MP0001661_extended_life_span | 0.70705423 |
| 122 | * MP0000538_abnormal_urinary_bladder | 0.70635545 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.69893483 |
| 124 | MP0002254_reproductive_system_inflammat | 0.69075933 |
| 125 | MP0001243_abnormal_dermal_layer | 0.68786572 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.68726190 |
| 127 | MP0003948_abnormal_gas_homeostasis | 0.68657658 |
| 128 | MP0002733_abnormal_thermal_nociception | 0.68331743 |
| 129 | MP0005646_abnormal_pituitary_gland | 0.68324956 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.68278997 |
| 131 | MP0004134_abnormal_chest_morphology | 0.68149903 |
| 132 | MP0000920_abnormal_myelination | 0.67001345 |
| 133 | MP0004130_abnormal_muscle_cell | 0.65889096 |
| 134 | MP0005220_abnormal_exocrine_pancreas | 0.65359884 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.64187633 |
| 136 | MP0002971_abnormal_brown_adipose | 0.63413239 |
| 137 | MP0000579_abnormal_nail_morphology | 0.63396219 |
| 138 | MP0001968_abnormal_touch/_nociception | 0.62471521 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.62390577 |
| 140 | MP0009763_increased_sensitivity_to | 0.61317981 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.60985142 |
| 142 | MP0008874_decreased_physiological_sensi | 0.60954488 |
| 143 | MP0005448_abnormal_energy_balance | 0.59305365 |
| 144 | MP0005423_abnormal_somatic_nervous | 0.59136647 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.58679390 |
| 146 | MP0002090_abnormal_vision | 0.57591534 |
| 147 | MP0003186_abnormal_redox_activity | 0.57454357 |
| 148 | * MP0003635_abnormal_synaptic_transmissio | 0.56832517 |
| 149 | MP0005670_abnormal_white_adipose | 0.56237217 |
| 150 | MP0002064_seizures | 0.55642326 |
| 151 | MP0005334_abnormal_fat_pad | 0.54819621 |
| 152 | MP0002063_abnormal_learning/memory/cond | 0.54633669 |
| 153 | MP0009053_abnormal_anal_canal | 0.53709437 |
| 154 | MP0008872_abnormal_physiological_respon | 0.53692563 |
| 155 | * MP0003632_abnormal_nervous_system | 0.53688499 |
| 156 | MP0004142_abnormal_muscle_tone | 0.53052129 |
| 157 | MP0002837_dystrophic_cardiac_calcinosis | 0.52644333 |
| 158 | MP0001529_abnormal_vocalization | 0.52545814 |
| 159 | MP0001486_abnormal_startle_reflex | 0.52309552 |
| 160 | MP0009745_abnormal_behavioral_response | 0.50831448 |
| 161 | MP0001905_abnormal_dopamine_level | 0.50682012 |
| 162 | MP0010368_abnormal_lymphatic_system | 0.50285616 |
| 163 | MP0000778_abnormal_nervous_system | 0.50091135 |
| 164 | MP0005084_abnormal_gallbladder_morpholo | 0.48942351 |
| 165 | MP0002735_abnormal_chemical_nociception | 0.48926738 |
| 166 | MP0005645_abnormal_hypothalamus_physiol | 0.47989608 |
| 167 | MP0005187_abnormal_penis_morphology | 0.47474614 |
| 168 | MP0005266_abnormal_metabolism | 0.46913796 |
| 169 | MP0006036_abnormal_mitochondrial_physio | 0.46257749 |
| 170 | MP0002572_abnormal_emotion/affect_behav | 0.46170617 |
| 171 | MP0002736_abnormal_nociception_after | 0.45890099 |
| 172 | MP0006035_abnormal_mitochondrial_morpho | 0.45703754 |
| 173 | MP0001756_abnormal_urination | 0.45611529 |
| 174 | MP0002069_abnormal_eating/drinking_beha | 0.44683676 |
| 175 | MP0001984_abnormal_olfaction | 0.44344243 |
| 176 | MP0003953_abnormal_hormone_level | 0.43434313 |
| 177 | * MP0003631_nervous_system_phenotype | 0.42116337 |
| 178 | MP0001177_atelectasis | 0.41402777 |
| 179 | MP0003633_abnormal_nervous_system | 0.40992197 |
| 180 | MP0002909_abnormal_adrenal_gland | 0.40817101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.55765332 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.15281787 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.90079798 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.22615209 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.15796530 |
| 6 | Xanthomatosis (HP:0000991) | 6.10031819 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.08655881 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.51881523 |
| 9 | Complement deficiency (HP:0004431) | 5.48472893 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.51817646 |
| 11 | Epidermoid cyst (HP:0200040) | 4.42995728 |
| 12 | Hyperammonemia (HP:0001987) | 4.35500809 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.31087072 |
| 14 | Ketosis (HP:0001946) | 4.21248095 |
| 15 | Joint hemorrhage (HP:0005261) | 4.19002439 |
| 16 | Absent frontal sinuses (HP:0002688) | 4.15942197 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15488025 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09464444 |
| 19 | Hyperglycinemia (HP:0002154) | 4.06718855 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.04117026 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.02068993 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01751120 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.97723286 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89870445 |
| 25 | Abnormality of complement system (HP:0005339) | 3.84266869 |
| 26 | Asymmetry of the thorax (HP:0001555) | 3.79222762 |
| 27 | Premature rupture of membranes (HP:0001788) | 3.79184280 |
| 28 | Fat malabsorption (HP:0002630) | 3.76764166 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.59486038 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59486038 |
| 31 | Hyperglycinuria (HP:0003108) | 3.40173269 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.38719745 |
| 33 | Vascular tortuosity (HP:0004948) | 3.34925704 |
| 34 | Arterial tortuosity (HP:0005116) | 3.33462716 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.28216395 |
| 36 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.27999263 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23828672 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.20505108 |
| 39 | J-shaped sella turcica (HP:0002680) | 3.20361293 |
| 40 | Spontaneous abortion (HP:0005268) | 3.17422544 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.16829556 |
| 42 | Aortic dissection (HP:0002647) | 3.12983552 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09459355 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.09352768 |
| 45 | Ketoacidosis (HP:0001993) | 3.03751995 |
| 46 | Skin nodule (HP:0200036) | 3.01569047 |
| 47 | Broad metatarsal (HP:0001783) | 3.00085301 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.87059019 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.79316265 |
| 50 | Bladder diverticulum (HP:0000015) | 2.78195067 |
| 51 | Steatorrhea (HP:0002570) | 2.77012343 |
| 52 | Microglossia (HP:0000171) | 2.76600249 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.75937833 |
| 54 | Soft skin (HP:0000977) | 2.74774176 |
| 55 | Abnormality of the frontal sinuses (HP:0002687) | 2.74467052 |
| 56 | Mitral stenosis (HP:0001718) | 2.71779303 |
| 57 | Morphological abnormality of the middle ear (HP:0008609) | 2.65816761 |
| 58 | Atrophic scars (HP:0001075) | 2.65510944 |
| 59 | Cholecystitis (HP:0001082) | 2.63349211 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.63349211 |
| 61 | Neonatal short-limb short stature (HP:0008921) | 2.63090110 |
| 62 | Hyperacusis (HP:0010780) | 2.62577141 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58558965 |
| 64 | Amyloidosis (HP:0011034) | 2.58380267 |
| 65 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.56782407 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.56718062 |
| 67 | Shallow orbits (HP:0000586) | 2.55544455 |
| 68 | Ankle contracture (HP:0006466) | 2.51165559 |
| 69 | Syringomyelia (HP:0003396) | 2.50323994 |
| 70 | Spinal cord lesions (HP:0100561) | 2.50323994 |
| 71 | Long toe (HP:0010511) | 2.48031437 |
| 72 | Neonatal onset (HP:0003623) | 2.47449177 |
| 73 | Biconcave vertebral bodies (HP:0004586) | 2.46083230 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 2.42647361 |
| 75 | Bowel diverticulosis (HP:0005222) | 2.42457368 |
| 76 | Genu recurvatum (HP:0002816) | 2.40996156 |
| 77 | Thin bony cortex (HP:0002753) | 2.40541310 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.39717943 |
| 79 | Deformed sella turcica (HP:0002681) | 2.39687747 |
| 80 | Gout (HP:0001997) | 2.39178100 |
| 81 | Metabolic acidosis (HP:0001942) | 2.37608043 |
| 82 | Myocardial infarction (HP:0001658) | 2.37003035 |
| 83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36788349 |
| 84 | Irritability (HP:0000737) | 2.36526174 |
| 85 | Cholelithiasis (HP:0001081) | 2.32041160 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.31333533 |
| 87 | Cervical subluxation (HP:0003308) | 2.31028110 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.31009511 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.27585893 |
| 90 | Enlarged penis (HP:0000040) | 2.25035094 |
| 91 | Lethargy (HP:0001254) | 2.24656520 |
| 92 | Abnormality of the ischium (HP:0003174) | 2.23391706 |
| 93 | Abnormality of dentin (HP:0010299) | 2.23222405 |
| 94 | Buphthalmos (HP:0000557) | 2.22966101 |
| 95 | Aortic aneurysm (HP:0004942) | 2.22727724 |
| 96 | Cerebral aneurysm (HP:0004944) | 2.21768988 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 2.20041985 |
| 98 | Mitral valve prolapse (HP:0001634) | 2.19907803 |
| 99 | Spastic diplegia (HP:0001264) | 2.19575504 |
| 100 | Acanthocytosis (HP:0001927) | 2.17247307 |
| 101 | Wormian bones (HP:0002645) | 2.17033956 |
| 102 | Flat cornea (HP:0007720) | 2.16699161 |
| 103 | Cerebral edema (HP:0002181) | 2.16568821 |
| 104 | Glomerulonephritis (HP:0000099) | 2.15454083 |
| 105 | Renovascular hypertension (HP:0100817) | 2.14236574 |
| 106 | Ulnar claw (HP:0001178) | 2.13601118 |
| 107 | Status epilepticus (HP:0002133) | 2.08617353 |
| 108 | Thin ribs (HP:0000883) | 2.07034577 |
| 109 | Late onset (HP:0003584) | 2.07022687 |
| 110 | Mitral regurgitation (HP:0001653) | 2.04524883 |
| 111 | Breech presentation (HP:0001623) | 2.04326266 |
| 112 | Hypoventilation (HP:0002791) | 2.02385669 |
| 113 | Congenital glaucoma (HP:0001087) | 2.02113272 |
| 114 | Neurofibrillary tangles (HP:0002185) | 2.01186977 |
| 115 | Vascular calcification (HP:0004934) | 2.00961803 |
| 116 | Exostoses (HP:0100777) | 2.00271645 |
| 117 | Type 1 muscle fiber predominance (HP:0003803) | 1.98600100 |
| 118 | Brushfield spots (HP:0001088) | 1.98313279 |
| 119 | Hypoplastic ischia (HP:0003175) | 1.98274556 |
| 120 | Dicarboxylic aciduria (HP:0003215) | 1.97794304 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97794304 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 1.96827161 |
| 123 | Wide anterior fontanel (HP:0000260) | 1.96268942 |
| 124 | Hyperextensible skin (HP:0000974) | 1.95273978 |
| 125 | Aortic regurgitation (HP:0001659) | 1.94168309 |
| 126 | Deviation of the hallux (HP:0010051) | 1.93240095 |
| 127 | Osteoarthritis (HP:0002758) | 1.93100057 |
| 128 | Abnormality of the sella turcica (HP:0002679) | 1.91912292 |
| 129 | Renal duplication (HP:0000075) | 1.90972589 |
| 130 | Hallux valgus (HP:0001822) | 1.90751631 |
| 131 | Patellar dislocation (HP:0002999) | 1.90233259 |
| 132 | Pterygium (HP:0001059) | 1.89464886 |
| 133 | Craniofacial dystonia (HP:0012179) | 1.88598519 |
| 134 | Opisthotonus (HP:0002179) | 1.87490749 |
| 135 | Enlarged kidneys (HP:0000105) | 1.86887827 |
| 136 | Torticollis (HP:0000473) | 1.86848218 |
| 137 | Deformed tarsal bones (HP:0008119) | 1.86570026 |
| 138 | Overgrowth (HP:0001548) | 1.86542377 |
| 139 | Concave nail (HP:0001598) | 1.86316209 |
| 140 | Back pain (HP:0003418) | 1.83493435 |
| 141 | Coronal craniosynostosis (HP:0004440) | 1.83285910 |
| 142 | Rickets (HP:0002748) | 1.83134530 |
| 143 | Turricephaly (HP:0000262) | 1.83027177 |
| 144 | Arnold-Chiari malformation (HP:0002308) | 1.82474175 |
| 145 | Malnutrition (HP:0004395) | 1.82350130 |
| 146 | Vertebral arch anomaly (HP:0008438) | 1.81888843 |
| 147 | Hypophosphatemic rickets (HP:0004912) | 1.81811205 |
| 148 | Cerebral inclusion bodies (HP:0100314) | 1.81646315 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.80847611 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.80847611 |
| 151 | Insidious onset (HP:0003587) | 1.80020594 |
| 152 | Termporal pattern (HP:0011008) | 1.80020594 |
| 153 | Ulnar bowing (HP:0003031) | 1.79922968 |
| 154 | Cardiovascular calcification (HP:0011915) | 1.79553662 |
| 155 | Infantile muscular hypotonia (HP:0008947) | 1.79492103 |
| 156 | Fragile skin (HP:0001030) | 1.78130989 |
| 157 | Abnormality of vitamin metabolism (HP:0100508) | 1.77840406 |
| 158 | Vomiting (HP:0002013) | 1.76976312 |
| 159 | Spinal rigidity (HP:0003306) | 1.76730711 |
| 160 | Calcaneovalgus deformity (HP:0001848) | 1.75590051 |
| 161 | Joint laxity (HP:0001388) | 1.75038111 |
| 162 | Elfin facies (HP:0004428) | 1.74383015 |
| 163 | Germ cell neoplasia (HP:0100728) | 1.73462180 |
| 164 | Gingival bleeding (HP:0000225) | 1.73123077 |
| 165 | Spastic paraparesis (HP:0002313) | 1.73082896 |
| 166 | Spinal cord compression (HP:0002176) | 1.73035028 |
| 167 | Focal dystonia (HP:0004373) | 1.73015595 |
| 168 | Lymphangioma (HP:0100764) | 1.71922809 |
| 169 | Pheochromocytoma (HP:0002666) | 1.71678111 |
| 170 | Esophageal varix (HP:0002040) | 1.71491742 |
| 171 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.69446668 |
| 172 | Akinesia (HP:0002304) | 1.68808119 |
| 173 | Pancreatitis (HP:0001733) | 1.68047624 |
| 174 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.66291273 |
| 175 | Macroorchidism (HP:0000053) | 1.65283123 |
| 176 | Abnormality of the Achilles tendon (HP:0005109) | 1.64938995 |
| 177 | Broad face (HP:0000283) | 1.64045014 |
| 178 | Midline defect of the nose (HP:0004122) | 1.63980520 |
| 179 | Thrombophlebitis (HP:0004418) | 1.63814204 |
| 180 | Insomnia (HP:0100785) | 1.62878083 |
| 181 | Megalocornea (HP:0000485) | 1.62843597 |
| 182 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.61778570 |
| 183 | Paraparesis (HP:0002385) | 1.61637571 |
| 184 | Alkalosis (HP:0001948) | 1.61574615 |
| 185 | Hemorrhage of the eye (HP:0011885) | 1.60820422 |
| 186 | Hammertoe (HP:0001765) | 1.60533013 |
| 187 | Hyporeflexia of lower limbs (HP:0002600) | 1.60527226 |
| 188 | Blue sclerae (HP:0000592) | 1.59065211 |
| 189 | Camptodactyly of toe (HP:0001836) | 1.58757127 |
| 190 | Aplasia involving bones of the extremities (HP:0009825) | 1.58724495 |
| 191 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.58724495 |
| 192 | Aplasia of the phalanges of the hand (HP:0009802) | 1.58724495 |
| 193 | Neoplasm of the heart (HP:0100544) | 1.56966600 |
| 194 | Bicornuate uterus (HP:0000813) | 1.56746172 |
| 195 | Peritonitis (HP:0002586) | 1.56529703 |
| 196 | Short nail (HP:0001799) | 1.55446623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.18831162 |
| 2 | SCYL2 | 3.64792013 |
| 3 | MUSK | 3.58996955 |
| 4 | SIK1 | 3.30647877 |
| 5 | FGFR4 | 3.29232947 |
| 6 | ERN1 | 2.91782670 |
| 7 | ERBB4 | 2.84677495 |
| 8 | PIK3CA | 2.75956729 |
| 9 | MAP2K4 | 2.66870866 |
| 10 | FGFR2 | 2.53519372 |
| 11 | EPHA4 | 2.34190583 |
| 12 | EEF2K | 2.08136091 |
| 13 | INSRR | 1.99486911 |
| 14 | WNK3 | 1.83510034 |
| 15 | EPHA3 | 1.79953451 |
| 16 | LMTK2 | 1.71152290 |
| 17 | KSR2 | 1.69069129 |
| 18 | RPS6KB2 | 1.67680208 |
| 19 | NEK6 | 1.60761929 |
| 20 | ERBB2 | 1.59539225 |
| 21 | MAP3K4 | 1.57008095 |
| 22 | RET | 1.55435589 |
| 23 | RPS6KA2 | 1.54822756 |
| 24 | NTRK3 | 1.54530900 |
| 25 | MAPKAPK3 | 1.47970586 |
| 26 | TTN | 1.46785741 |
| 27 | MINK1 | 1.44054027 |
| 28 | PHKG2 | 1.42391678 |
| 29 | PHKG1 | 1.42391678 |
| 30 | TRIB3 | 1.41752809 |
| 31 | NTRK2 | 1.37947272 |
| 32 | ICK | 1.35764559 |
| 33 | PAK3 | 1.34875636 |
| 34 | NTRK1 | 1.34238093 |
| 35 | CSNK1G2 | 1.33875578 |
| 36 | MYLK | 1.33755113 |
| 37 | MARK1 | 1.31050280 |
| 38 | PAK6 | 1.28403920 |
| 39 | PNCK | 1.28229680 |
| 40 | CSNK1G3 | 1.24619900 |
| 41 | PKN2 | 1.22798906 |
| 42 | IRAK2 | 1.20419555 |
| 43 | RIPK1 | 1.20086186 |
| 44 | MTOR | 1.18995447 |
| 45 | MAP3K9 | 1.18719719 |
| 46 | MAPK11 | 1.17795896 |
| 47 | RPS6KB1 | 1.17543607 |
| 48 | CHUK | 1.16212353 |
| 49 | MAP3K13 | 1.14278252 |
| 50 | DAPK2 | 1.13518014 |
| 51 | SGK223 | 1.12972385 |
| 52 | SGK494 | 1.12972385 |
| 53 | CSNK1G1 | 1.12306086 |
| 54 | KSR1 | 1.11404895 |
| 55 | LATS2 | 1.10285418 |
| 56 | PAK2 | 1.07676053 |
| 57 | EPHB1 | 1.06020666 |
| 58 | ILK | 1.05001444 |
| 59 | MAP3K7 | 1.04211610 |
| 60 | GRK6 | 1.00834356 |
| 61 | EPHB2 | 0.99975669 |
| 62 | PRKCZ | 0.97510663 |
| 63 | SMG1 | 0.96746571 |
| 64 | MAP2K2 | 0.95388997 |
| 65 | PINK1 | 0.93993737 |
| 66 | TYRO3 | 0.89998792 |
| 67 | PRKCG | 0.89580044 |
| 68 | MAP3K12 | 0.89493074 |
| 69 | TAOK3 | 0.89016706 |
| 70 | PIK3CG | 0.86426207 |
| 71 | TESK1 | 0.86144238 |
| 72 | PDGFRA | 0.85939074 |
| 73 | PKN1 | 0.85388530 |
| 74 | CAMK2G | 0.84831956 |
| 75 | MAPK4 | 0.82263297 |
| 76 | CAMK1G | 0.81180276 |
| 77 | MAP3K10 | 0.80650885 |
| 78 | PTK6 | 0.79765315 |
| 79 | STK39 | 0.78993198 |
| 80 | SGK3 | 0.78374555 |
| 81 | EPHA2 | 0.77622040 |
| 82 | LIMK1 | 0.76337787 |
| 83 | ABL2 | 0.76114733 |
| 84 | ROCK2 | 0.76022328 |
| 85 | LATS1 | 0.75828345 |
| 86 | PDGFRB | 0.74360972 |
| 87 | MAP2K7 | 0.73973165 |
| 88 | DYRK2 | 0.72948584 |
| 89 | MAP2K1 | 0.72717326 |
| 90 | MST1R | 0.72349133 |
| 91 | CAMK2D | 0.71289112 |
| 92 | PRKCH | 0.70087354 |
| 93 | CAMK1D | 0.69667886 |
| 94 | CAMKK1 | 0.69217078 |
| 95 | SGK2 | 0.68944208 |
| 96 | FER | 0.68619825 |
| 97 | CDK11A | 0.68259205 |
| 98 | CSNK1A1L | 0.68189809 |
| 99 | BRD4 | 0.68040095 |
| 100 | CDK5 | 0.67794140 |
| 101 | PTK2 | 0.66381252 |
| 102 | ARAF | 0.66340137 |
| 103 | RPS6KL1 | 0.65810968 |
| 104 | RPS6KC1 | 0.65810968 |
| 105 | TRPM7 | 0.65331233 |
| 106 | MET | 0.63445741 |
| 107 | IRAK1 | 0.61445876 |
| 108 | JAK2 | 0.60770277 |
| 109 | CASK | 0.60130093 |
| 110 | PRKD3 | 0.59887024 |
| 111 | WNK4 | 0.59817625 |
| 112 | CAMK2A | 0.59528654 |
| 113 | MAP3K2 | 0.59500380 |
| 114 | PDPK1 | 0.59098882 |
| 115 | PRKAA2 | 0.58766539 |
| 116 | PRKACG | 0.58650931 |
| 117 | CDK7 | 0.56969129 |
| 118 | PAK4 | 0.56955597 |
| 119 | MAPK13 | 0.56670031 |
| 120 | BCR | 0.56386397 |
| 121 | MAPK12 | 0.54312496 |
| 122 | ROCK1 | 0.53234815 |
| 123 | RPS6KA6 | 0.52369804 |
| 124 | UHMK1 | 0.52225574 |
| 125 | PRKCQ | 0.52067457 |
| 126 | DYRK1B | 0.49357077 |
| 127 | SIK2 | 0.49093243 |
| 128 | RPS6KA4 | 0.49039205 |
| 129 | OXSR1 | 0.48302122 |
| 130 | MAPK7 | 0.47981695 |
| 131 | FRK | 0.47219246 |
| 132 | MOS | 0.47149068 |
| 133 | FGFR1 | 0.44247484 |
| 134 | PRKAA1 | 0.43103565 |
| 135 | CSNK1D | 0.42993356 |
| 136 | DDR2 | 0.40912539 |
| 137 | DAPK3 | 0.39858010 |
| 138 | MAP3K6 | 0.39302588 |
| 139 | CLK1 | 0.38728058 |
| 140 | CAMK2B | 0.38179107 |
| 141 | TAF1 | 0.38164682 |
| 142 | MAPK8 | 0.37928473 |
| 143 | MARK2 | 0.37455250 |
| 144 | DYRK1A | 0.37380040 |
| 145 | PRKD2 | 0.37379739 |
| 146 | PRKCI | 0.37075122 |
| 147 | CDK14 | 0.36857199 |
| 148 | CDK15 | 0.35901455 |
| 149 | CDK18 | 0.35526625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56146785 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.99760208 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49392193 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16386664 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05960784 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01372298 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72544740 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64534765 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51953492 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45850852 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43434437 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29633762 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27824005 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.08017398 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03817275 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99314373 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.96129651 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93060504 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.89734566 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89461316 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85933183 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81672169 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80945911 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80453932 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79523359 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.75077325 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70501528 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64272297 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.60236200 |
| 30 | Thyroid cancer_Homo sapiens_hsa05216 | 1.59993116 |
| 31 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.59796091 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.58031685 |
| 33 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.57540513 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.55985147 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55463831 |
| 36 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.53791573 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52745194 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52349927 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51203384 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.49454417 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44804207 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44672414 |
| 43 | Melanoma_Homo sapiens_hsa05218 | 1.44207920 |
| 44 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.44121071 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42806935 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.42763672 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42280197 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.41990965 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41514577 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.40832520 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40398892 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37980754 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 1.36326620 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.36309857 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34468035 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.34295285 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34163169 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 1.32227086 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32132485 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.31014462 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27504049 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.25796920 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23177464 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 1.22567152 |
| 65 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.22219884 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21626985 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21348066 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21171451 |
| 69 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20564847 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17392340 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16085342 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15661790 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14722732 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13207867 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12506663 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.11699037 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08627778 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07788941 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07151363 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05497760 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.04790067 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04682546 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04524301 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 1.04149458 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 1.04015194 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03378789 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 1.00857024 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00054873 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99004677 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98676704 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98473947 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98354396 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.94997388 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.92493238 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90402633 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.89988540 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89344550 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89107674 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.87632921 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86794586 |
| 101 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86351176 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85004005 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84684839 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84430352 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83670749 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.81206456 |
| 107 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78454271 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.77650903 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76725500 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74252967 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71621554 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70526394 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70420723 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70286735 |
| 115 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70223100 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68803531 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68026692 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67641863 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.67453878 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67127678 |
| 121 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65559535 |
| 122 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64950219 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63864089 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.62953247 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62941803 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62600593 |
| 127 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60363773 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59735670 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58814442 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57427904 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54622707 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53626621 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51466088 |
| 134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50821246 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50175387 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48125453 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45594993 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44253603 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39190099 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38138511 |
| 141 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32583424 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28852493 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24991025 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23763313 |
| 145 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23510217 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.23489485 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16402930 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11656030 |
| 149 | GABAergic synapse_Homo sapiens_hsa04727 | 0.11313106 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10108644 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08323049 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03120188 |
| 153 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02625545 |
| 154 | Axon guidance_Homo sapiens_hsa04360 | 0.02604795 |
| 155 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1413291 |
| 156 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1369083 |
| 157 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.1298067 |
| 158 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1283753 |
| 159 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.1135436 |
| 160 | Dopaminergic synapse_Homo sapiens_hsa04728 | -0.1133983 |
| 161 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1094657 |
| 162 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1053533 |
| 163 | Insulin secretion_Homo sapiens_hsa04911 | -0.1042522 |
| 164 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0823948 |
| 165 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0551321 |
| 166 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0520278 |
| 167 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0426884 |
| 168 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.0372250 |
| 169 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0330849 |
| 170 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0198552 |
| 171 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.0115339 |
| 172 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0057659 |

